The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CASI Pharmaceuticals, Inc(NASDAQ:CASI) 
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. The company offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell t...
Website: http://www.casipharmaceuticals.com
Founded: 1991
Full Time Employees: 125
Sector: Healthcare
Industry: Biotechnology
CASI Pharmaceuticals Days Payable Outstanding ttm (DPO)
CASI Pharmaceuticals Days Receivable Outstanding ttm (DSO)
CASI Pharmaceuticals Days Inventory Outstanding ttm (DIO)
CASI Pharmaceuticals Op Cashflow Per Share ttm
CASI Pharmaceuticals Free Cashflow Per Share ttm
CASI Pharmaceuticals Cash Per Share ttm
CASI Pharmaceuticals P/S ratio ttm
CASI Pharmaceuticals (GAAP) P/E ratio ttm
CASI Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.